Aquestive Therapeutics leverages its PharmFilm platform to develop Anaphylm, a sublingual epinephrine film, a $1B+ market.

Johnson and Johnson stock has reached an all-time high, hitting a price of 189.92 USD, with a substantial year-to-date return of 33.76%. According to InvestingPro analysis, the stock currently shows ...

Discover how a ₹1 lakh annual SIP in equity funds for 15 years can build significant wealth. Learn about equity funds, SIP ...

We outline 4 case studies from the past 12 months and 3 new companies to which we’re applying the lessons learned for future ...

The latest environmental studies signal success for Victory Metals (ASX:VTM) at its North Stanmore heavy rare earths project ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for ...

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1000 women who say they developed brain tumors ...

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1000 women who say they developed brain tumours after taking the popular contraceptive injection Depo-Provera.

Investing.com -- Bioaffinity Technologies Inc (NASDAQ:BIAF) stock soared 79% in premarket trading Friday after the biotechnology company released three new case studies highlighting the effectiveness ...

It's not only rare earths where this company has ample growth potential. There is still a long way to go before the company completes its three-stage business plan. With interest in shoring up the ...

Neutra, a naturalized American citizen who emigrated from Austria, was instrumental in creating Southern California’s midcentury-modern design aesthetic, while the Case Study Houses, a program ...